New patent for Apellis Pharms drug EMPAVELI

Annual Drug Patent Expirations for EMPAVELI Empaveli is a drug marketed by Apellis Pharms and is included in one NDA. It is available from one supplier. There are nine patents…

The post New patent for Apellis Pharms drug EMPAVELI appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog